Natalie Grover

Natalie Grover, MD is an Associate Professor of Medicine at the University of North Carolina at Chapel Hill School of Medicine, where she serves as Clinical Director of the Cellular Therapy Program and Leader of the Cell Therapy POD within the Department of Medicine, Division of Hematology. She maintains an active clinical practice treating patients with various lymphoma types while leading cutting-edge research in cellular therapies.

Education:

• Undergraduate: Massachusetts Institute of Technology
• Medical School: Case Western Reserve University (2007-2011)
• Residency: University of Virginia (2011-2014), Internal Medicine
• Fellowship: University of North Carolina at Chapel Hill (2014-2017), Hematology/Oncology

Dr. Grover specializes in lymphoma treatment with a particular focus on CAR-T cell therapy and cellular immunotherapies. Her research interests include improving the efficacy and safety of CAR-T cell therapy, investigating treatment resistance mechanisms, and developing innovative approaches for lymphoma patients. She leads multiple CAR-T cell clinical trials and collaborates with translational researchers to advance novel therapies from bench to bedside. Her work spans both aggressive and indolent lymphomas, with special attention to Non-Hodgkin and Hodgkin Lymphoma.

Analysis of Dr. Grover's recent publications reveals a strong emphasis on CAR-T cell therapy applications across various lymphoma subtypes. Her research spans clinical trials, safety optimization, and real-world outcomes assessment, with particular focus on CD19 and CD30 targeting strategies. She actively investigates treatment resistance mechanisms and explores combination approaches to improve patient outcomes. Her work increasingly addresses the application of cellular therapies to T-cell lymphomas and rare lymphoma subtypes.

Dr. Grover maintains an active clinical practice at UNC Hospitals Adult Oncology Clinics at the N.C. Basnight Cancer Hospital, where she sees patients with leukemia and lymphoma. She is board certified in Internal Medicine and Medical Oncology. Her clinical work focuses on providing patient-centered care with technical excellence, as reflected in her consistently high patient satisfaction ratings (4.8/5.0 overall, with 9/10 comments highlighting exceptional care). She emphasizes clear communication, compassionate treatment discussions, and collaborative decision-making with her patients.